Cadrenal Therapeutics, Inc. Stock Issued During Period, Shares, Other
Cadrenal Therapeutics, Inc. (CVKD) had Stock Issued During Period, Shares, Other of 10.00 thousand shares as of 2025-06-29, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesOther · last filed 2026-03-31
- 2025-06-29: Stock Issued During Period, Shares, Other 10.00K shares.
| Period end | Stock Issued During Period, Shares, Other |
|---|---|
| 2025-06-29 | 10.00K shares 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |